Ardent Health SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Other events · Financial statements and exhibits
AI summary, unreviewedArdent Health discloses 8.0 million-share secondary offering by selling stockholders at $14.50, with company repurchasing 1.5 million shares for $13.7025 million...
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedArdent Health to acquire Boone Health for $47 million in cash, adding a 392-bed Missouri hospital system
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedArdent Health Q3 2026 GAAP EPS of $0.31 beats $0.24 consensus on $1.625 billion revenue; adjusted EBITDA guidance midpoint raised 1.5%, EPS guidance midpoint below consensus
Departure/appointment of directors or officers
AI summary, unreviewedArdent Health recharacterizes former CEO Martin Bonick's exit as a termination for Cause, cancels about $4.5 million severance and unvested PRSUs
Other events · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits